A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by ...
A one-fifth dose of Bavarian Nordic’s mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose ...
Lower dose of monkeypox vaccine is found to be safe with equal six-week antibody response, promising for vaccination strategies.
The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
At one dose, the vaccine was found to be 75.2% effective. Back in 2022, when initial supplies were constrained, the FDA issued an emergency use authorization (EUA) allowing intradermal ...
Two human cases of bird flu have been confirmed so far, with one likely resulting from exposure to dairy cows.
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
World Immunization Week: 507 vaccines in late-stage development, 88 using mRNA tech to prevent TB, malaria, flu, COVID-19, ...
The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY) vaccine candidate ... as 2 doses 6 months apart ...
and over 100 million doses could be deployed in the coming months." Vaccine Makers Stand Ready ASPR's industry partners include CSL Seqirus, GSK, and Sanofi, which have H5N1 vaccines licensed for ...
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control ...
With a final decision expected next February, MenABCWY combines the protective elements of GSK’s existing vaccines to target the five primary serogroups of Neisseria meningitidis. GSK announced that ...